A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) Herman, J. M., Chang, D. T., Goodman, K. A., Wild, A. T., Laheru, D., Zheng, L., Diaz, L. A., Dung Thi Le, D. T., Raman, S. P., Leal, J. P., Chaudhry, M. A., Sugar, E., Columbo, L. A., Tom, A., Limaye, M. R., Edil, B. H., Oteiza, K., Hacker-Prietz, A., Wolfgang, C. L., Koong, A. AMER SOC CLINICAL ONCOLOGY. 2012

View details for Web of Science ID 000318009805038